Understanding Anti-CD47 and Radiation Effect on Group 3 Medulloblastoma
Cindy Campbell2026-02-02T17:10:13-05:00Huntsman Cancer Research Institute In 2023, the Ty Louis Campbell (TLC) Foundation supported the project “Leveraging Super-Multi-Parameter Fluorescence Activated Cell Sorting Analysis to Obtain a Comprehensive Understanding of the Immune System Consequences of Irradiation and Anti-CD47 Treatments in Group 3 Medulloblastoma” with a $100,000 donation. Medulloblastoma (MB) is the most common malignant primary brain tumor [...]



